BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.01B |
| 3 |
Amazon
AMZN
|
+$960M |
| 4 |
Alibaba
BABA
|
+$859M |
| 5 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$642M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$702M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$682M |
| 3 |
CME Group
CME
|
+$627M |
| 4 |
Nektar Therapeutics
NKTR
|
+$598M |
| 5 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$585M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.05% |
| 2 | Financials | 15.61% |
| 3 | Healthcare | 12.97% |
| 4 | Industrials | 10.15% |
| 5 | Consumer Discretionary | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Vanguard Morningstar Growth ETF
VUG
$220B
| $1.01M | ﹤0.01% |
42,930
+6,642
| +18% | +$162K |
|
|
MARK
3802
DELISTED
Remark Holdings, Inc.
MARK
| $1.01M | ﹤0.01% |
17,875
+9,610
| +116% | +$888K |
|
|
SMRT
3803
DELISTED
Stein Mart Inc
SMRT
| $1.01M | ﹤0.01% |
666,820
-5,644
| -0.8% | -$5.28K |
|
|
SSI
3804
DELISTED
Stage Stores Inc
SSI
| $1.01M | ﹤0.01% |
464,623
-4,051
| -0.9% | -$7.6K |
|
|
LITS
3805
Lite Strategy Inc
LITS
$32.8M
| $1.01M | ﹤0.01% |
24,436
-378
| -2% | -$16.5K |
|
3806
Stellus Capital Investment Corp
SCM
$217M
| $1.01M | ﹤0.01% |
87,866
-13,934
| -14% | -$168K |
|
|
CDTX
3807
DELISTED
Cidara Therapeutics
CDTX
| $998K | ﹤0.01% |
12,477
+9,059
| +265% | +$1.24M |
|
3808
Broadwind
BWEN
$93.6M
| $970K | ﹤0.01% |
441,217
-4,878
| -1% | -$11.9K |
|
3809
Cytosorbents Corp
CTSO
$22.7M
| $958K | ﹤0.01% |
135,806
-4,331
| -3% | -$32.7K |
|
|
DMK
3810
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $954K | ﹤0.01% |
3,892
-68
| -2% | -$17.8K |
|
3811
Inuvo
INUV
$15.1M
| $949K | ﹤0.01% |
103,444
-31
| -0% | -$276 |
|
|
LUNA
3812
DELISTED
Luna Innovations Incorporated
LUNA
| $948K | ﹤0.01% |
292,592
-718
| -0.2% | -$1.8K |
|
|
NGD
3813
DELISTED
New Gold Inc
NGD
| $940K | ﹤0.01% |
364,428
+1,921
| +0.5% | +$5.4K |
|
|
SHI
3814
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $932K | ﹤0.01% |
15,187
-10,526
| -41% | -$635K |
|
3815
Galectin Therapeutics
GALT
$196M
| $930K | ﹤0.01% |
196,157
-1,984
| -1% | -$9.24K |
|
|
QADB
3816
DELISTED
QAD Inc. Class B
QADB
| $893K | ﹤0.01% |
28,509
-950
| -3% | -$31.3K |
|
|
NAVB
3817
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $891K | ﹤0.01% |
123,736
-779
| -0.6% | -$5.83K |
|
3818
iShares California Muni Bond ETF
CMF
$4.55B
| $888K | ﹤0.01% |
15,205
+115
| +0.8% | +$6.72K |
|
|
AATC
3819
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
| $876K | ﹤0.01% |
206,316
+378
| +0.2% | +$1.22K |
|
|
RAS
3820
DELISTED
RAIT Financial Trust
RAS
| $874K | ﹤0.01% |
5,419,693
-21,293
| -0.4% | -$7.8K |
|
|
HMNF
3821
DELISTED
HMN Financial Inc
HMNF
| $869K | ﹤0.01% |
46,849
-5,466
| -10% | -$104K |
|
|
BBOX
3822
DELISTED
Black Box Corp
BBOX
| $861K | ﹤0.01% |
430,891
-165,455
| -28% | -$453K |
|
3823
American Realty Investors
ARL
$246M
| $859K | ﹤0.01% |
44,296
-1,801
| -4% | -$25.1K |
|
3824
US Global Investors
GROW
$35.5M
| $856K | ﹤0.01% |
338,553
-3,646
| -1% | -$12.7K |
|
3825
Jakks Pacific
JAKK
$301M
| $856K | ﹤0.01% |
40,733
-80
| -0.2% | -$1.89K |
|
Similar funds
BlackRock's Q1 2018 Portfolio in Review
As of Q1 2018, BlackRock held 5,137 positions worth $2.09T, down 0.47% from $2.1T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock's Q1 2018 filing shows 155 new, 2,323 increased, 1,970 reduced and 164 closed positions. Its largest new stake was Dropbox: 10,477,103 shares worth $327M. The largest sale was Lockheed Martin, an estimated $702M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q1 2018 buy was Dropbox: 10,477,103 shares worth $327M.
- BlackRock added most to Johnson & Johnson in Q1 2018, an estimated $1.06B increase.
- BlackRock's biggest Q1 2018 reduction was Lockheed Martin, cutting an estimated $702M.
- BlackRock fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $585M.
- BlackRock's ten largest holdings make up 14% of its $2.09T portfolio in Q1 2018.
- BlackRock opened 155 new positions and closed 164 in Q1 2018.
- BlackRock's portfolio value fell 0.47% quarter-over-quarter to $2.09T.
Based on BlackRock's 13F filing for Q1 2018, filed 9 May 2018.